Zhiqi Yin Selected Research

rhein

1/2021	Design and Evaluation of Rhein-Based MRI Contrast Agents for Visualization of Tumor Necrosis Induced by Combretastatin A-4 Disodium Phosphate.
12/2019	Rhein-based necrosis-avid MRI contrast agents for early evaluation of tumor response to microwave ablation therapy.
1/2019	SPECT Imaging of Treatment-Related Tumor Necrosis Using Technetium-99m-Labeled Rhein.
11/2018	Synthesis and Biological Evaluation of Rhein-Based MRI Contrast Agents for in Vivo Visualization of Necrosis.
1/2017	Radiolabeled Rhein as Small-Molecule Necrosis Avid Agents for Imaging of Necrotic Myocardium.
2/2016	Discovery of Radioiodinated Monomeric Anthraquinones as a Novel Class of Necrosis Avid Agents for Early Imaging of Necrotic Myocardium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhiqi Yin Research Topics

Disease

25	Necrosis 01/2021 - 05/2014
17	Neoplasms (Cancer) 01/2022 - 09/2013
4	Myocardial Infarction 01/2018 - 11/2015
4	Hyperlipidemias (Hyperlipidemia) 12/2015 - 12/2013
3	Body Weight (Weight, Body) 07/2022 - 12/2015
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2008
3	Inflammation (Inflammations) 05/2021 - 04/2014
3	Obesity 12/2015 - 05/2015
2	Insulin Resistance 07/2022 - 04/2014
2	Constipation 09/2021 - 02/2021
2	Residual Neoplasm 12/2019 - 05/2014
2	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2016
1	Arthritis (Polyarthritis) 01/2022
1	Gout 01/2022
1	Hyperuricemia 01/2022
1	Bronchitis 05/2021
1	Non-alcoholic Fatty Liver Disease 05/2021
1	Burns 05/2021
1	Chilblains (Chilblain) 05/2021
1	Alcoholic Fatty Liver 05/2021
1	Fibrosis (Cirrhosis) 05/2021
1	Pneumonia (Pneumonitis) 05/2021
1	Hyperthermia 01/2019
1	Crohn Disease (Crohn's Disease) 05/2018
1	Melanoma (Melanoma, Malignant) 04/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Neoplasm Metastasis (Metastasis) 09/2017
1	Ovarian Epithelial Carcinoma 09/2017

Drug/Important Bio-Agent (IBA)

11	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2014
7	fosbretabulin (combretastatin A4)IBA 03/2021 - 05/2014
7	hypericinIBA 01/2018 - 05/2014
6	rheinIBA 01/2021 - 02/2016
4	LipidsIBA 05/2021 - 05/2015
4	Contrast MediaIBA 01/2021 - 11/2018
3	AcidsIBA 01/2022 - 01/2016
3	Phosphates (Orthophosphate)IBA 01/2021 - 01/2016
3	Ethanol (Ethyl Alcohol)IBA 01/2018 - 01/2017
3	Apolipoprotein B-48IBA 12/2017 - 05/2015
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 07/2022 - 01/2019
2	CholesterolIBA 07/2022 - 05/2021
2	Loperamide (Imodium)FDA LinkGeneric 09/2021 - 02/2021
2	LaxativesIBA 09/2021 - 02/2021
2	TriterpenesIBA 01/2019 - 08/2008
2	Biological ProductsIBA 11/2018 - 04/2014
2	Iodine-131IBA 01/2018 - 02/2015
2	ApolipoproteinsIBA 12/2017 - 08/2015
2	AnthraquinonesIBA 02/2016 - 01/2016
2	RadiopharmaceuticalsIBA 02/2016 - 06/2015
2	protohypericinIBA 01/2016 - 09/2015
2	dihydroxydianthroneIBA 11/2015 - 05/2014
2	Herbal TeasIBA 08/2015 - 12/2013
2	IntegrasesIBA 07/2014 - 12/2010
1	Triglycerides (Triacylglycerol)IBA 07/2022
1	Blood Glucose (Blood Sugar)IBA 07/2022
1	Glucose (Dextrose)FDA LinkGeneric 07/2022
1	chrysinIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	InflammasomesIBA 01/2022
1	NucleotidesIBA 01/2022
1	TeaIBA 01/2022
1	NLR ProteinsIBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	(1-6)-alpha-glucomannan (glucomannan)IBA 09/2021
1	Polysaccharides (Glycans)IBA 09/2021
1	Dietary Fiber FDA Link 09/2021
1	OligosaccharidesIBA 09/2021
1	kaempferol-3-O-glucuronideIBA 05/2021
1	ginsenoside RdIBA 03/2021
1	Capsules (Microcapsules)IBA 02/2021
1	AlkanesIBA 01/2021
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2020
1	3,3'-diindolylmethane (diindolylmethane)IBA 01/2020
1	Acetic Acid (Vinegar)FDA LinkGeneric 12/2019
1	GadoliniumIBA 12/2019
1	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 12/2019
1	rho-Associated KinasesIBA 01/2019
1	EDDA (NiEDDA)IBA 01/2019
1	Peptidoglycan (Murein)IBA 05/2018
1	MethyltransferasesIBA 04/2018
1	Biomarkers (Surrogate Marker)IBA 04/2018
1	hypomycin AIBA 01/2018
1	naphthazarinIBA 01/2018
1	Bisbenzimidazole (Hoechst 33258)IBA 01/2018
1	FlavonoidsIBA 01/2018
1	microsomal triglyceride transfer proteinIBA 12/2017
1	Mitogen-Activated Protein KinasesIBA 12/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2017
1	diphosphoric acid (pyrophosphoric acid)IBA 09/2017
1	CateninsIBA 09/2017
1	Inorganic Pyrophosphatase (Pyrophosphatase, Inorganic)IBA 09/2017
1	SodiumIBA 08/2017
1	SaltsIBA 08/2017
1	Radioisotopes (Radionuclides)IBA 01/2016
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 01/2016

Therapy/Procedure

16	Therapeutics 01/2021 - 05/2014
3	Traditional Medicine (Folk Remedies) 12/2015 - 12/2013
2	Oral Administration 07/2022 - 12/2017
2	Radiotherapy 11/2017 - 09/2015
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2021
1	Intravenous Administration 11/2017